The biopharmaceutical industry is pushing for continuous manufacturing (CM) due to the shift in global pharmaceutical needs from blockbuster drugs to customized rare disease drugs, and the need for creating a faster rollout of innovative treatments, especially during pandemics, according to Korea BI
CHA Biomedical Group announced on Wednesday it will participate in the world's largest bio exhibition, 2023 BIO International Convention, to be be held in Boston, from June 5 to 9.Affiliates of CHA Biomedical Group -- Matica Biotechnology, CHA Biotech, and CHA Vaccine Research Institute -- will expl
Korea Biomedical Review is publishing a series of articles to analyze the top 10 Korean pharmaceutical and biopharma companies with the largest market capitalizations listed on the main bourse, Kospi, and the tech-heavy Kosdaq. The series aims to reflect key industrial issues and the flow of the cap
Amid the mounting anticipation for the BIO International Convention 2023, Korean contract development and manufacturing organization (CDMO) companies are strategically positioning themselves to reinforce their stature as global frontrunners in the industry.According to industry officials, Samsung Bi
With the “BIO International Convention 2023” two weeks away, providing a battleground for pharmaceutical and biotech companies worldwide, attention is on the Korean companies that have thrown their hats into the ring.BIO 2023 is the world’s largest comprehensive biotechnology convention attended by
“We want to develop a fecal microbial transplantation (FMT)-based treatment in the form of an oral capsule with a defined set of purely cultivated microbes to address the downfalls of FMT,” said the winner of the proof-of-concept study at a microbiome conference.Korea Biomedical Review (KBR) spoke w
Regulatory bodies like the FDA require the genomic sequence of the strain to ensure there are no plasmids, phages, or antimicrobial resistance (AMR) genes and this is where we can support Korean live biotherapeutic products (LBP) companies, said an expert in the microbiome industry.Korea Biomedical
Many may not be aware but outside of Finland’s charm as a Nordic country, Finland is also famous for something else. Due to its relatively small population, Finland is Europe’s digital health epicenter, among the leading countries in digitalization and innovation.With the help of Business Finland, D
Similar to other Asian nations grappling with declining birth rates, Singapore experienced a record-low total birth rate of 1.05 in 2022, surpassing the previous records of 1.1 in 2020 and 1.12 in 2021.Singapore's low birth rate remains a pressing demographic concern, posing challenges to its aging
BIO Korea closed the curtains on its three-day biopharmaceutical conference on Friday, drawing an impressive crowd of nearly 30,000 participants from 730 companies representing 51 countries.Among them, the Australian, Canadian, and German biopharma delegates were heavily represented at the exhibitio
In a promising development for the field of clinical research, the adoption of decentralized clinical trials (DCT) as a hybrid approach appears increasingly likely, said executives of IQVIA, the world’s largest clinical research organization (CRO). The traditional investigator will always be at the
In the Asia Pacific region, Korea has emerged as a leading player in the microbiome industry, with multiple genome-based companies entering the field in the last three years. The industry has experienced explosive growth, with the number of preclinical and clinical drug candidates increasing from 18
Recently, the Danish Embassy in Korea announced the launch of the Korea-Denmark Hospital Alliance to strengthen healthcare exchanges between leading hospitals in Korea and Denmark. As Denmark seeks to develop its bioindustry, the government has positioned health counselors in eight different countri
Vaccines are often overlooked and only got much-needed attention during the Covid-19 pandemic. Now, it's time some of that spotlight shifts over to bacterial infections.Bacterial vaccines often receive less attention compared to viral infectious diseases because bacterial infections are not perceive
AstraZeneca is renowned for its blockbuster oncology drugs. However, the Covid-19 pandemic has recently shifted the company's focus to its infectious disease portfolio, including its Covid-19 vaccine, Vaxzevria, and treatment, Evusheld.During the recent Global Vaccine and Immunization Research Forum
Korea Biomedical Review is publishing a series of interview articles highlighting the most influential female executives in the Korean biotech and biopharma industry. This is the third installment. -- Ed. At the young age of 34, Janice Jung leads a successful team that introduced Lunit INSIGHT MMG,
The Covid-19 pandemic highlighted the stark global disparities in vaccine access and this spurred regions to start thinking of a regional response to future pandemics such as building regional manufacturing capacity.Regional manufacturing capacity emerged as a cross-cutting theme in the sessions at